MedCity News

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Bloomberg L.P.

Flagship-Backed Generate Biomedicines Raises $400 Million in IPO

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
BioPharma Dive

Generate caps a strong month for biotech IPOs with $400M offering

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...
FierceBiotech

Generate plans $425M IPO to bankroll antibody's phase 3 asthma trials

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
The Business Journals

Generate:Biomedicines targets $400M IPO amid biotech market thaw

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company aims to ...
The Business Journals

Generate:Biomedicines eyes public markets as AI drug advances to late-stage trials

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
The New York Times

Champions League permutations: Who needs what to progress on the final night of the league phase?

All 36 Champions League teams will be in action simultaneously on Wednesday in the final round of league-phase play Robbie Jay Barratt - AMA/Getty Images The league phase of the 2025-26 Champions ...
CNBC

Your income-generating investments could create a tax bill. How to prepare for the season

The tax-filing season is officially underway, and investors – especially those who are holding income-generating assets – will want to prepare to pay the tax man. The Internal Revenue Service began ...
The New York Times

Silicon Valley Wants to Build A.I. That Can Improve A.I. on Its Own

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
Wired

Grok Is Generating Sexual Content Far More Graphic Than What's on X

A WIRED review of outputs hosted on Grok’s official website shows it’s being used to create violent sexual images and videos, as well as content that includes apparent minors. Unlike on X, where ...